Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.04.30.591647

DeepKin: precise estimation of in-depth relatedness and its application in UK Biobank

Abstract

Accurately estimating relatedness between samples is crucial in genetics and epidemiological analysis. Using genome-wide single nucleotide polymorphisms (SNPs), it is now feasible to measure realized relatedness even in the absence of pedigree. However, the sampling variation in SNP-based measures and factors affecting method-of-moments relatedness estimators have not been fully explored, whilst static cut-off thresholds have traditionally been employed to classify relatedness levels for decades. Here, we introduce the deepKin framework as a moment-based relatedness estimation and inference method that incorporates data-specific cut-off threshold determination. It addresses the limitations of previous moment estimators by leveraging the sampling variance of the estimator to provide statistical inference and classification. Key principles in relatedness estimation and inference are provided, including inferring the critical value required to reject the hypothesis of unrelatedness, which we refer to as the deepest significant relatedness, determining the minimum effective number of markers, and understanding the impact on statistical power. Through simulations, we demonstrate that deepKin accurately infers both unrelated pairs and relatives with the support of sampling variance. We then apply deepKin to two subsets of the UK Biobank dataset. In the 3K Oxford subset, tested with four sets of SNPs, the SNP set with the largest effective number of markers and correspondingly the smallest expected sampling variance exhibits the most powerful inference for distant relatives. In the 430K British White subset, deepKin identifies 212,120 pairs of significant relatives and classifies them into six degrees. Additionally, cross-cohort significant relative ratios among 19 assessment centers located in different cities are geographically correlated, while within-cohort analyses indicate both an increase in close relatedness and a potential increase in diversity from north to south throughout the UK. Overall, deepKin presents a novel framework for accurate relatedness estimation and inference in biobank-scale datasets. For biobank-scale application we have implemented deepKin as an R package, available in the GitHub repository (https://github.com/qixininin/deepKin).

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Zhang, Q.-X., Jayasinghe, D., Lee, S. H., Xu, H., Chen, G.-B.. 2024-05-01. DeepKin: precise estimation of in-depth relatedness and its application in UK Biobank. https://doi.org/10.1101/2024.04.30.591647

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗